News Center
[2018 Heavyweight Arrival] Injectable Esomeprazole Sodium Emerges
Release time:
2018-01-10
近日，丽珠制药厂、丽珠医药研究所收到国家食品药品监督管理总局核准签发的《药品注册批件》（批件号：2017S00556）。注射用艾普拉唑钠历时9年研发，终于获批，为2018年开年的重磅好消息。
Recently, Lizhu Pharmaceutical Factory and Lizhu Pharmaceutical Research Institute received the "Drug Registration Approval" issued by the National Medical Products Administration (Approval No.: 2017S00556). The injectable Esomeprazole Sodium has been developed over 9 years and has finally been approved, marking a significant piece of good news at the beginning of 2018.
The injectable Esomeprazole Sodium and its raw materials have undergone 9 years of research and development, costing over 60 million yuan, and are innovative drugs developed independently by the company. They mainly treat bleeding from peptic ulcers. The injectable Esomeprazole Sodium has advantages such as long acid suppression time, small individual differences, and few drug interactions, allowing for once-a-day administration.
Ms. Hou Xuemei, the chief scientist of the group research institute, expressed her feelings: "After nearly ten years of research and development, the injectable Esomeprazole Sodium and its raw materials have been approved for production, and the formulation has received a new drug certificate! This fully demonstrates that there are no problems that cannot be solved, no obstacles that cannot be overcome, and hardships make us stronger! Thank you to our hardworking team, thank you to the Lizhu alumni who contributed to this project! Thank you to the country for supporting innovative drugs! Thank you for the good times we are in! At the same time, I am proud of Lizhu's strength!"
Ms. Hou Xuemei's words not only represent the feelings of all Lizhu researchers but also reflect the sentiments of all Lizhu people. In the social media feeds, everyone is sharing the news, excitedly celebrating this hard-won approval.
The media also rushed to report this significant news in the industry: major portals such as Tencent, Phoenix, Sina, and Sohu reported the news of "injectable Esomeprazole Sodium and its raw materials approved for production" at the first opportunity, cheering for the significant breakthrough achievements in national pharmaceuticals!
Related Information